Acetyl-CoA synthetase (AceCS) provides acetyl-CoA for different physiological processes, such as fatty acid and cholesterol synthesis, as well as the citric acid cycle. We show here that the cytosolic isoform of this enzyme, AceCS1, is expressed during mouse development. In the embryonic stage E9.5 AceCS1 transcripts localize in the cephalic region. At E10.5 the cephalic expression intensifies and transcripts appear also in the spinal cord and in the dorsal root ganglions. During organogenesis AceCS1 is expressed in the liver from E11.5. The AceCS1 gene is expressed also in the testes from E12.5 onwards and expression localizes in the interstitial Leydig cells. In the ovaries, expression is transient and AceCS1 transcripts are detected from E13.5 to E15.5 in the ovarian interstitial component. In the kidneys AceCS1 transcripts appear in a subset of the renal tubules at E16.5 and remains in these structures in newborns. Hence, expression of AceCS1 is developmentally regulated suggesting a role for AceCS1 during embryogenesis. q
Results
Human cytosolic acetyl-CoA synthetase (AceCS1) was recently characterized as an enzyme regulated by sterol regulatory element-binding proteins (SREBPs) (Luong et al., 2000; Ikeda et al., 2001) . We had previously isolated the mouse cDNA clone (AF216873) and to better understand the possible functions of this enzyme in the mouse we determined the tissue distribution of AceCS1 mRNA in adult mice by Northern blotting and during embryonic development by whole mount and tissue section in situ hybridization techniques.
Northern blot hybridization ( Fig. 1 ) revealed a single transcript of about 3 kb. The highest expression of AceCS1 was found in the kidneys, ovaries and testes of the adult mouse. The liver, lungs, heart, brain and muscles also expressed the AceCS1 gene.
Whole mount in situ hybridization using embryos from E9.5, E10.5 and E11.5 was performed (Fig. 2) . At E9.5 ( Fig.  2A ) AceCS1 transcripts appeared in the cephalic region, with the strongest expression in the forebrain. Cephalic expression intensified further at E10.5 (Fig. 2B ) and at E11.5 (Fig. 2C) as judged by whole mount in situ hybridization and transcripts were detected in the spinal cord and in the dorsal root ganglions as well (Fig. 2D, E) . At E11.5 AceCS1 expression was observed also in the liver (Fig. 2C) .
The analysis of E12.5 embryos revealed that AceCS1 was also expressed in the male gonad (Fig. 3A) and the expression was maintained at older embryonic ages ( Fig. 3B-D) . In female no expression was detected in the ovaries at E12.5 Chomczynski and Sacchi (1987) , in each lane. Membrane was hybridized with the full length AceCS1 cDNA, and (B) stained with methylene blue as a loading control. (Fig. 3E ). AceCS1 transcripts appeared at E13.5 (Fig. 3F ) and whole mount staining intensified further at E14.5 (Fig.  3G) . From E15.5 ovarian expression decreased gradually (Fig. 3H ). Kidney expression of the AceCS1 gene was not detected at these stages.
In embryos from E14.5, E15.5, E16.5 and in newborn mice urogenital AceCS1 expression was monitored using section in situ hybridization. Typical expression patterns are shown in Fig. 4 . In testes a strong expression of AceCS1 was detected in the interstitial Leydig cells at all ages studied (Fig. 4A shows the expression pattern in newborns). Ovaries accumulated AceCS1 transcripts transiently peaking at E14.5 (Fig. 4B) and downregulated by E16.5 (data not shown). In the kidneys the AceCS1 signals were detected from E16.5 in a subset of renal tubules and expression remained in these structures in newborns (Fig.  4C) . A sense probe was used as control and it did not show any localized expression (data not shown).
In summary the AceCS1 gene has a specific expression pattern during the development of the mouse. These results suggest that although AceCS1 may have a general function as providing acetyl-CoA for fatty acid, cholesterol synthesis and the citric acid cycle, it may also have a specific role during organogenesis.
Materials and methods

Whole mount and section immunostaining
Whole mount and section in situ hybridization was performed based on standard procedures (Wilkinson, Fig. 2 . Expression pattern of AceCS1 determined by whole mount in situ hybridization. Mouse embryo at E9.5 (A) showed specific AceCS1 expression in the cephalic region. At E10.5 (B) and E11.5 (C) staining intensifies in the brain and AceCS1 transcripts can be detected in the spinal cord and in the dorsal root ganglions (D,E, enlarged segments from E11.5 embryo). At E11.5 (C) AceCS1 signal appears also in the liver. Li, liver; SC, spinal cord; D, dorsal root ganglions. Fig. 3 . Expression of AceCS1 gene in developing mouse urogenital blocks. Whole mount in situ hybridization was performed to study AceCS1 gene expression in the urogenital blocks of mouse embryos between E12.5 and E15.5. Antisense RNA probes were labeled with digoxigenin. All samples were processed similarly at the same time. In males (A-D) AceCS1 gene expression appears at E12.5 in the testes. Female ovaries (E-H) show increasing AceCS1 expression after E13.5 and expression is decreasing gradually after E15.5. ov, ovary; k, kidney; t, testis. 1992). Digoxigenin labeled AceCS1 antisense and sense probes were prepared from the mouse clone AF216873 in the pBluescript SK-vector. For the antisense probe the vector was linearized with BamHI and a 1370-bp long (bases 1165-2535) RNA probe was synthesized with T7 RNA polymerase. The full length (2535 bp) sense probe was synthesized with T3 RNA polymerase after Hind III linearization.
Sex typing
The sex of E11.5 and E12.5 embryos was determined by polymerase chain reaction (PCR) method. A 353-bp region from the last intron of the mouse Zfy gene was amplified with the following primers: 5 0 -GGAAATGCTGTTA-CATGTTGACC-3 0 and 5 0 -CAGCTTGACCTGCAAAG-GAAG-3 0 that corresponds to positions 47-70 and 378-399, respectively (Chang et al., 1994) . 
